Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MagDI U.S. Registry

NCT: NCT06928545 · RECRUITING

NCT IDNCT06928545
StatusRECRUITING
Start Date2025-03-28
Completion2027-04
SponsorGT Metabolic Solutions, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

Assess the incidence and severity of internal hernia and bowel obstruction at one year in a U.S. population following use of the MagDI System to create side-to-side duodeno-ileal anastomoses.

Frequently Asked Questions

What is MagDI U.S. Registry?

MagDI U.S. Registry is a clinical trial registered under NCT06928545. Current status: RECRUITING.

What is the status of NCT06928545?

The current status of NCT06928545 (MagDI U.S. Registry) is: RECRUITING.

When did MagDI U.S. Registry start?

MagDI U.S. Registry started on 2025-03-28.

Related Devices

K242086MagDI System (MAG-01, DS-01)Gt Metabolic Solutions, Inc. K243359MagDI System (MAG-02, DS-01)Gt Metabolic Solutions, Inc. K253102GT Metabolic MagDI System (MAG-01, MAG-02, DS-01)Gt Metabolic Solutions, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑